v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2023 $ 345,121 $ 2 $ 533,764   $ (188,645)
Balance (in Shares) at Dec. 31, 2023   24,360,233      
Issuance of common stock upon exercise of stock options 806   806    
Issuance of common stock upon exercise of stock options (in Shares)   95,467      
Issuance of common stock under employee stock purchase plan 245   245    
Sale of common stock in at-the-market offerings 14,790   14,790    
Sale of common stock in at-the-market offerings (in shares)   234,449      
Stock-based compensation expense 4,058   4,058    
Issuance of common stock under employee stock purchase plan (in shares)   5,736      
Net Income (Loss) (26,949)       (26,949)
Balance at Mar. 31, 2024 338,071 $ 2 553,663   (215,594)
Balance (in Shares) at Mar. 31, 2024   24,695,885      
Balance at Dec. 31, 2023 345,121 $ 2 533,764   (188,645)
Balance (in Shares) at Dec. 31, 2023   24,360,233      
Foreign currency translation adjustments 6        
Net Income (Loss) (53,301)        
Balance at Jun. 30, 2024 488,829 $ 3 730,832 $ (60) (241,946)
Balance (in Shares) at Jun. 30, 2024   29,707,997      
Balance at Mar. 31, 2024 338,071 $ 2 553,663   (215,594)
Balance (in Shares) at Mar. 31, 2024   24,695,885      
Issuance of common stock upon exercise of stock options 567   567    
Issuance of common stock upon exercise of stock options (in Shares)   68,112      
Stock-based compensation expense 4,091   4,091    
Foreign currency translation adjustments 6     6  
Unrealized gain on marketable securities (66)     (66)  
Sale of common stock in underwritten offering 172,512 $ 1 172,511    
Sale of common stock in underwritten offering (in Shares)   4,944,000      
Net Income (Loss) (26,352)       (26,352)
Balance at Jun. 30, 2024 488,829 $ 3 730,832 (60) (241,946)
Balance (in Shares) at Jun. 30, 2024   29,707,997      
Balance at Dec. 31, 2024 443,587 $ 3 741,297 289 (298,002)
Balance (in Shares) at Dec. 31, 2024   29,865,030      
Issuance of common stock upon exercise of stock options 575   575    
Issuance of common stock upon exercise of stock options (in Shares)   91,524      
Issuance of common stock upon vesting of restricted stock units (in shares)   83,672      
Issuance of common stock under employee stock purchase plan 287   287    
Stock-based compensation expense 6,363   6,363    
Foreign currency translation adjustments 14     14  
Unrealized gain on marketable securities 232     232  
Issuance of common stock under employee stock purchase plan (in shares)   7,814      
Sale of common stock in underwritten offering 234,003   234,003    
Sale of common stock in underwritten offering (in Shares)   4,533,182      
Sale of pre-funded warrants in underwritten offering 9,386   9,386    
Net Income (Loss) (34,085)       (34,085)
Balance at Mar. 31, 2025 660,362 $ 3 991,911 535 (332,087)
Balance (in Shares) at Mar. 31, 2025   34,581,222      
Balance at Dec. 31, 2024 443,587 $ 3 741,297 289 (298,002)
Balance (in Shares) at Dec. 31, 2024   29,865,030      
Foreign currency translation adjustments (1)        
Net Income (Loss) (89,332)        
Balance at Jun. 30, 2025 614,165 $ 3 1,001,223 273 (387,334)
Balance (in Shares) at Jun. 30, 2025   34,694,882      
Balance at Mar. 31, 2025 660,362 $ 3 991,911 535 (332,087)
Balance (in Shares) at Mar. 31, 2025   34,581,222      
Issuance of common stock upon exercise of stock options 892   892    
Issuance of common stock upon exercise of stock options (in Shares)   110,230      
Stock-based compensation expense (in Shares)   0      
Stock-based compensation expense 8,420   8,420    
Foreign currency translation adjustments (15)     (15)  
Unrealized gain on marketable securities (247)     (247)  
Net Income (Loss) (55,247)       (55,247)
Balance at Jun. 30, 2025 $ 614,165 $ 3 $ 1,001,223 $ 273 $ (387,334)
Balance (in Shares) at Jun. 30, 2025   34,694,882